UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Annals of oncology, 2018-03, Vol.29 (3), p.700-706

2018

Volltextzugriff (PDF)

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial

Annals of oncology, 2023-10, Vol.34 (10), p.907-919

2023

Volltextzugriff (PDF)

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Annals of oncology, 2019-08, Vol.30 (8), p.1321-1328

2019

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

Annals of oncology, 2010-02, Vol.21 (2), p.376-381

2010

Volltextzugriff (PDF)

Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort

Annals of oncology, 2015-01, Vol.26 (1), p.221-230

2015

Volltextzugriff (PDF)

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Annals of oncology, 2018-10, Vol.29 (10), p.2143-2143

2018

Volltextzugriff (PDF)

Oral bisphosphonate use and lung cancer incidence among postmenopausal women

Annals of oncology, 2018-06, Vol.29 (6), p.1476-1485

2018

Volltextzugriff (PDF)

Genomic characterization of thymic epithelial tumors in a real-world dataset

ESMO open, 2023-10, Vol.8 (5), p.101627, Article 101627

2023

Volltextzugriff (PDF)

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.76 (3), p.410-415

2012

Volltextzugriff (PDF)

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

Annals of oncology, 2018-08, Vol.29 (8), p.1701-1709

2018

Volltextzugriff (PDF)

MTE19.01 How I Treat Advanced Stage Thymic Malignancy Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S222-S223

Wakelee, H.

2018

Volltextzugriff (PDF)

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer

British journal of cancer, 2014-02, Vol.110 (3), p.602-608

2014

Volltextzugriff (PDF)

eXalt3: Phase III randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase positive non-small cell lung cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii543-viii543

2018

Volltextzugriff (PDF)

PC 03.03 Liquid Biopsy

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1666-S1667

Wakelee, H.

2017

Volltextzugriff (PDF)

Prediction of PD-1 immunotherapy (IO) response for KRAS mutated non-small cell lung cancer (NSCLC) based on co-mutations using a computational biological model

Annals of oncology, 2018-10, Vol.29, p.viii510-viii511

2018

Volltextzugriff (PDF)

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

Annals of oncology, 2019-04, Vol.30, p.ii48-ii48

2019

Volltextzugriff (PDF)

Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii541-viii542

2018

Volltextzugriff (PDF)

Treatment, overall survival, and costs in patients with ALK-positive non-small-cell lung cancer after crizotinib monotherapy

Current medical research and opinion, 2015-08, Vol.31 (8), p.1587-1597

2015

Volltextzugriff (PDF)

I.21 Checkpoint Inhibitor Combinations Among Themselves and with Chemotherapy

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1166-S1166

2019

Volltextzugriff (PDF)

MS04.03 Adjuvant PD-(L)1 Checkpoint Inhibitors

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S156-S157

2019

Volltextzugriff (PDF)

YI01.03 Making the Most of WCLC: A Guide for First Time Attendees

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S1115-S1116

2019

Volltextzugriff (PDF)

Association of nonmelanoma skin cancer with second noncutaneous malignancy in the Women's Health Initiative

British journal of dermatology (1951), 2017-02, Vol.176 (2), p.512-516

2017

Volltextzugriff (PDF)

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

British journal of cancer, 2012-08, Vol.107 (4), p.604-611

2012

Volltextzugriff (PDF)

3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement

European journal of cancer (1990), 2015-09, Vol.51, p.S598-S598

2015

Volltextzugriff (PDF)

3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M

European journal of cancer (1990), 2015-09, Vol.51, p.S636-S636

2015

Volltextzugriff (PDF)

1 – 25 von 269

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(255)

Publikationsform

Artikel
(268)
Buchkapitel
(1)

Sprache

Englisch
(269)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(78)
Humans
(74)
Oncology
(68)
Lung Neoplasms - Drug Therapy
(37)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(35)
Female
(35)
Male
(32)
Middle Aged
(32)
Aged
(31)
Lung Neoplasms - Pathology
(25)
Respiratory System
(23)
Adult
(22)
Carcinoma, Non-Small-Cell Lung - Pathology
(20)
Biological And Medical Sciences
(18)
Lung Neoplasms - Genetics
(18)
Hematology, Oncology And Palliative Medicine
(17)
Lung Cancer
(17)
Medical Sciences
(17)
Carcinoma, Non-Small-Cell Lung - Genetics
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

Active and passive smoking in relation to lung cancer incidence in the Women's Health Initiative Observational Study prospective cohort

Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma

Oral bisphosphonate use and lung cancer incidence among postmenopausal women

Genomic characterization of thymic epithelial tumors in a real-world dataset

Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer

MTE19.01 How I Treat Advanced Stage Thymic Malignancy Patients

A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non-small cell lung cancer

eXalt3: Phase III randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase positive non-small cell lung cancer patients

PC 03.03 Liquid Biopsy

Prediction of PD-1 immunotherapy (IO) response for KRAS mutated non-small cell lung cancer (NSCLC) based on co-mutations using a computational biological model

Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC)

Treatment, overall survival, and costs in patients with ALK-positive non-small-cell lung cancer after crizotinib monotherapy

I.21 Checkpoint Inhibitor Combinations Among Themselves and with Chemotherapy

MS04.03 Adjuvant PD-(L)1 Checkpoint Inhibitors

YI01.03 Making the Most of WCLC: A Guide for First Time Attendees

Association of nonmelanoma skin cancer with second noncutaneous malignancy in the Women's Health Initiative

A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours

3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement

3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M

Suchergebnisse filtern